deltatrials
Completed PHASE1 INTERVENTIONAL 1-arm NCT00554827

Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

A Phase 1, Open-label Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Sponsor: Acrotech Biopharma Inc.

Conditions Cutaneous T-cell Lymphoma
Interventions Folic Acid Pralatrexate Vitamin B12
Updated 9 times since 2017 Last updated: Jan 2, 2020 Started: Aug 31, 2007 Primary completion: Jan 31, 2012 Completion: Feb 29, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Cutaneous T-cell Lymphoma, this trial is completed. The trial is conducted by Acrotech Biopharma Inc. and has accumulated 9 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Feb 2020 · 20 months · monthly snapshotCompleted~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotCompleted~Jan 2021 – ~Nov 2022 · 22 months · monthly snapshotCompleted~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 9 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE1

  5. Jan 2021 — Nov 2022 [monthly]

    Completed PHASE1

▶ Show 4 earlier versions

  1. Feb 2020 — Jan 2021 [monthly]

    Completed PHASE1

  2. Jun 2018 — Feb 2020 [monthly]

    Completed PHASE1

  3. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1

    First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Acrotech Biopharma Inc.
Data source: Acrotech Biopharma Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations